3-mercaptopropionic acid has been researched along with plx4032 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, XY; Ding, YT; Gao, ZX; Gu, JY; Li, YL; Ren, M; Shen, KJ; Wang, L; Wei, CY | 1 |
1 other study(ies) available for 3-mercaptopropionic acid and plx4032
| Article | Year |
|---|---|
Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.
Topics: 3-Mercaptopropionic Acid; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Melanoma; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sulfonamides; Vemurafenib | 2022 |